1. Home
  2. XLO vs IH Comparison

XLO vs IH Comparison

Compare XLO & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$8.45

Market Cap

56.9M

Sector

Health Care

ML Signal

N/A

Logo iHuman Inc.

IH

iHuman Inc.

N/A

Current Price

$1.08

Market Cap

58.8M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
XLO
IH
Founded
2016
1996
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
58.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
XLO
IH
Price
$8.45
$1.08
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $18.00
N/A
AVG Volume (30 Days)
★ 13.5K
2.4K
Earning Date
11-10-2026
12-28-2026
Dividend Yield
N/A
★ 9.35%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $43,766,000.00
N/A
Revenue This Year
$3.55
N/A
Revenue Next Year
$9.26
N/A
P/E Ratio
★ N/A
$7.30
Revenue Growth
★ 589.88
N/A
52 Week Low
$0.46
$1.00
52 Week High
$22.60
$2.99

Technical Indicators

Market Signals
Indicator
XLO
IH
Relative Strength Index (RSI) 45.17 33.47
Support Level $7.29 N/A
Resistance Level $9.35 $1.25
Average True Range (ATR) 0.67 0.03
MACD 0.05 -0.01
Stochastic Oscillator 58.97 7.28

Price Performance

Historical Comparison
XLO
IH

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

Share on Social Networks: